The Pharmacokinetics of GLA5PR Tablet According to the Renal Function

Clinical trial NCT03963362 · UNKNOWN

Trial details

NCT number: NCT03963362
Sponsor: GL Pharm Tech Corporation
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Neuropathic Pain

Start date: 2019-09-17
Primary completion: 2020-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.